{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:04:27Z","timestamp":1795089867150,"version":"4.10.2"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Current practice uses the latest measure of glycated hemoglobin (HbAlc) to facilitate clinical decision-making. Studies have demonstrated that HbAlc variability links the risk of death and complications of diabetes. However, the role of HbAlc variability is unclear in clinical practice. This systematic review summarized the evidence of visit-to-visit HbAlc variability regarding different metrics in micro- and macro-vascular complications and death in people with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched PubMed, EMBASE (via OVID), and Cochrane Central Register (CENTRAL, via OVID) for studies investigating the association between HbAlc variability and adverse outcomes in patients with type 2 diabetes and performed random-effects meta-analysis stratified by HbAlc variability metrics in terms of standard deviation (SD), coefficient of variation (CV), and HbAlc variability score (HVS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In people with type 2 diabetes, the highest quantile of all three HbAlc variability metrics (HbAlc-standard deviation [HbAlc-SD], HbAlc-coefficient of variance [HbAlc-CV], and HVS) is associated with increased risks of all-cause mortality, cardiovascular events, progression to chronic kidney disease, amputation, and peripheral neuropathy. For example, the hazard ratio of HbAlc-SD on all-cause mortality was l.89 with 95% confidence interval (95% CI) l.46\u20132.45 (HbAlc-CV l.47, 95% CI l.26\u2013l.72; HVS l.67, 95% CI l.34\u20132.09).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>High HbAlc variability leads to micro- and macro-vascular complications of type 2 diabetes and related death. People with type 2 diabetes and high HbAlc variability need additional attention and care for the potential adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002073","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T18:05:03Z","timestamp":1646417103000},"page":"2294-2300","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":34,"title":["Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"135","author":[{"given":"Furong","family":"Qu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Guideline and Rapid Recommendation, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Guideline and Rapid Recommendation, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixin","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Life Science, University of Chinese Academy of Science, Beijing 100101, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan R.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 9SY, Scotland, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"},{"name":"Department of Guideline and Rapid Recommendation, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"},{"name":"Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 9SY, Scotland, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"issue":"(Suppl 1)","key":"R1-20250603","first-page":"S73","article-title":"6. Glycemic targets: Standards of medical care in diabetes - 2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","article-title":"American association of clinical endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus","volume":"27","author":"Grunberger","year":"2021","journal-title":"Endocr Pract"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a metaanalysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2016.04.163","article-title":"Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: a meta-analysis of data from 58,160 patients in 13 randomized controlled trials","volume":"218","author":"Fang","year":"2016","journal-title":"Int J Cardiol"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40618-020-01410-6","article-title":"HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes","volume":"44","author":"Hu","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jdiacomp.2016.05.024","article-title":"Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study","volume":"30","author":"Wan","year":"2016","journal-title":"J Diabetes Complications"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1475-2840-12-98","article-title":"Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study","volume":"12","author":"Penno","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/dc12-2264","article-title":"HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study","volume":"36","author":"Penno","year":"2013","journal-title":"Diabetes Care"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/dc19-0823","article-title":"Visit-to-visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes","volume":"43","author":"Li","year":"2020","journal-title":"Diabetes Care"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-8587(18)30048-2","article-title":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study","volume":"6","author":"Forbes","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R14-20250603","article-title":"Glycemic variability, glycated hemoglobin, and cardiovascular complications: still a dilemma in clinical practice","author":"Ceriello","year":"2021","journal-title":"Adv Ther"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"f7450","DOI":"10.1136\/bmj.f7450","article-title":"Converting an odds ratio to a range of plausible relative risks for better communication of research findings","volume":"348","author":"Grant","year":"2014","journal-title":"BMJ"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/biom.13197","article-title":"Optimal approximate conversions of odds ratios and hazard ratios to risk ratios","volume":"76","author":"VanderWeele","year":"2020","journal-title":"Biometrics"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for metaanalysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"e115509","DOI":"10.1371\/journal.pone.0115509","article-title":"HbA1C variability and the risk of renal status progression in diabetes mellitus: A meta-analysis","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/dc18-1471","article-title":"Overall quality of care predicts the variability of key risk factors for complications in type 2 diabetes: an observational, longitudinal retrospective study","volume":"42","author":"Ceriello","year":"2019","journal-title":"Diabetes Care"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3325\/cmj.2015.56.357","article-title":"The association of lifestyle and stress with poor glycemic control in patients with diabetes mellitus type 2: a Croatian nationwide primary care cross-sectional study","volume":"56","author":"Bralic Lang","year":"2015","journal-title":"Croat Med J"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jcpt.12360","article-title":"Medication adherence may be more important than other behaviours for optimizing glycaemic control among low-income adults","volume":"41","author":"Osborn","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/dme.13435","article-title":"Characteristics of people with high visit-to-visit glycaemic variability in type 2 diabetes","volume":"35","author":"Noyes","year":"2018","journal-title":"Diabet Med"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.dsx.2018.04.004","article-title":"Hypoglycemia in type 2 diabetes mellitus patients: a review article","volume":"12","author":"Tourkmani","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2337\/dc09-2082","article-title":"Hypoglycemia, diabetes, and cardiovascular events","volume":"33","author":"Desouza","year":"2010","journal-title":"Diabetes Care"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"b4909","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: etrospective epidemiological analysis of the ACCORD study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"R28-20250603","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2013.04.015","article-title":"Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose","volume":"126","author":"Lin","year":"2013","journal-title":"Am J Med"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00125-014-3462-y","article-title":"Epigenetic mechanisms in diabetic complications and metabolic memory","volume":"58","author":"Reddy","year":"2015","journal-title":"Diabetologia"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:00:24Z","timestamp":1748962824000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":29,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002073","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]}}}